Evidence map›Paper›PMID 31374920›Full record

ReviewMarine drugs2019

Conversion of Chitin to Defined Chitosan Oligomers: Current Status and Future Prospects.

Christian Schmitz, Lilian González Auza, David Koberidze, Stefan Rasche, Rainer Fischer, Luisa Bortesi

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 168 citations in OpenAlex.

  1. Article
  2. Review
  3. Application of chitosan-based nanogels for dermal and transdermal delivery systems.Journal of materials science. Materials in medicine · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Chitosan processing waste nutrients compounds as a potential natural poultry premix.Journal of advanced veterinary and animal research · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. A new strain ofFrontiers in microbiology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Christian SchmitzAachen-Maastricht Institute for Biobased Materials, Maastricht University, Brightlands Chemelot Campus, Urmonderbaan 22, 6167 RD Geleen, The Netherlands. christian.schmitz@maastrichtuniversity.nl.
Lilian González AuzaAachen-Maastricht Institute for Biobased Materials, Maastricht University, Brightlands Chemelot Campus, Urmonderbaan 22, 6167 RD Geleen, The Netherlands.
David KoberidzeAachen-Maastricht Institute for Biobased Materials, Maastricht University, Brightlands Chemelot Campus, Urmonderbaan 22, 6167 RD Geleen, The Netherlands.
Stefan RascheAachen-Maastricht Institute for Biobased Materials, Maastricht University, Brightlands Chemelot Campus, Urmonderbaan 22, 6167 RD Geleen, The Netherlands.
Rainer FischerAachen-Maastricht Institute for Biobased Materials, Maastricht University, Brightlands Chemelot Campus, Urmonderbaan 22, 6167 RD Geleen, The Netherlands.
Luisa BortesiAachen-Maastricht Institute for Biobased Materials, Maastricht University, Brightlands Chemelot Campus, Urmonderbaan 22, 6167 RD Geleen, The Netherlands.
Maastricht University · NLIndiana Biosciences Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chitin is an abundant polysaccharide primarily produced as an industrial waste stream during the processing of crustaceans. Despite the limited applications of chitin, there is interest from the medical, agrochemical, food and cosmetic industries because it can be converted into chitosan and partially acetylated chitosan oligomers (COS). These molecules have various useful properties, including antimicrobial and anti-inflammatory activities. The chemical production of COS is environmentally hazardous and it is difficult to control the degree of polymerization and acetylation. These issues can be addressed by using specific enzymes, particularly chitinases, chitosanases and chitin deacetylases, which yield better-defined chitosan and COS mixtures. In this review, we summarize recent chemical and enzymatic approaches for the production of chitosan and COS. We also discuss a design-of-experiments approach for process optimization that could help to enhance enzymatic processes in terms of product yield and product characteristics. This may allow the production of novel COS structures with unique functional properties to further expand the applications of these diverse bioactive molecules.

Indexed as

AmidohydrolasesAnimalsChitinChitinasesChitosanCrustaceaGlycoside HydrolasesGreen Chemistry TechnologyIndustrial WasteAmidohydrolasesChitinChitinaseschitin deacetylaseChitosanchitosanaseGlycoside HydrolasesIndustrial Wastechitinchitosanchitosan oligomersdeacetylationdepolymerizationdesign of experimentsenzymatic conversion

Identifiers

PMID31374920
PMCPMC6723438
OpenAlexW2964832075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.